Hydralazine Hydrochloride Tablet
Product Images NDC 71205-072

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 71205-072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (94553560 82a0 4100 8857 3f678e34a5bc 01)

FDA Label Image

71205-072-90 (94553560 82a0 4100 8857 3f678e34a5bc 03)

71205-072-90 (94553560 82a0 4100 8857 3f678e34a5bc 03)
This is a description of Hydralazine HCI 50mg tablets. It is a prescription medication, with each tablet containing 50mg of Hydralazine Hydrochloride, USP. The tablets are circular and orange colored, with "50" debossed on one side and plain on the other. The tablets come in a bottle with 90 tablets. It is manufactured by Strides Shasun Limited in Bengaluru, India, and packaged by Proficient Rx in Thousand Oaks, California. It should be stored at 20°-25°C (68°-77°F), and kept out of the reach of children. Lot number, expiration date, and Product ID information are also given.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.